CoChat

Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes

Open access
Rickels, Michael R., DuBose, Stephanie N., Toschi, Elena, Beck, Roy W., Verdejo, Alandra S., Wolpert, Howard, Cummins, Martin J., Newswanger, Brett, Riddell, Michael C., T1D Exchange Mini-Dose Glucagon Exercise Study Group, Rickels, Michael, Peleckis, Amy, Evangelisti, Margaret, Dalton-Bakes, Cornelia, Fuller, Carissa, Toschi, Elena, Wolpsert, Howard, Middelbeek, Roeland, Cherng Jye, Louis Seow, Shahar, Jacqueline, Slyne, Christine, Edwards, Stephanie, Castillo, Astrid Atakov, DuBose, Stephanie N., Beck, Roy W., Verdejo, Alandra S., Cummins, Martin, Newswanger, Brett, Prestrelski, Steve · 2018 · Diabetes Care

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Patients with type 1 diabetes who do aerobic exercise often experience a drop in blood glucose concentration that can result in hypoglycemia. Current approaches to prevent exercise-induced hypoglycemia include reduction in insulin dose or ingestion of carbohydrates, but these strategies may still result in hypoglycemia or hyperglycemia. We sought to determine whether mini-dose glucagon (MDG) given subcutaneously before exercise could prevent subsequent glucose lowering and to compare the glycemic response to current approaches for mitigating exercise-associated hypoglycemia. RESEARCH DESIGN AND METHODS: We conducted a four-session, randomized crossover trial involving 15 adults with type 1 diabetes treated with continuous subcutaneous insulin infusion who exercised fasting in the morning at ∼55% VO2max for 45 min under conditions of no intervention (control), 50% basal insulin reduction, 40-g oral glucose tablets, or 150-μg subcutaneous glucagon (MDG). RESULTS: During exercise and early recovery from exercise, plasma glucose increased slightly with MDG compared with a decrease with control and insulin reduction and a greater increase with glucose tablets (P < 0.001). Insulin levels were not different among sessions, whereas glucagon increased with MDG administration (P < 0.001). Hypoglycemia (plasma glucose <70 mg/dL) was experienced by six subjects during control, five subjects during insulin reduction, and none with glucose tablets or MDG; five subjects experienced hyperglycemia (plasma glucose ≥250 mg/dL) with glucose tablets and one with MDG. CONCLUSIONS: MDG may be more effective than insulin reduction for preventing exercise-induced hypoglycemia and may result in less postintervention hyperglycemia than ingestion of carbohydrate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc18-0051

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 79

Metadata

Authors
Rickels, M. R., DuBose, S. N., Toschi, E., Beck, R. W., Verdejo, A. S., Wolpert, H., Cummins, M. J., Newswanger, B., Riddell, M. C., T1D Exchange Mini-Dose Glucagon Exercise Study Group, Rickels, M., Peleckis, A., Evangelisti, M., Dalton-Bakes, C., Fuller, C., Toschi, E., Wolpsert, H., Middelbeek, R., Cherng Jye, L. S., Shahar, J., Slyne, C., Edwards, S., Castillo, A. A., DuBose, S. N., Beck, R. W., Verdejo, A. S., Cummins, M., Newswanger, B., & Prestrelski, S.
Affiliations
  • Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
  • Joslin Diabetes Center (US)
  • Xeris Pharmaceuticals, Inc., Austin, TX
  • York University (CA)
Corresponding author
T1D Exchange Mini-Dose Glucagon Exercise Study Group
Venue
Diabetes Care
Published
2018-05-18
Volume
41
Issue
9
Pages
1909-1916
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2803450541
Cited by
79
References
25
Citations by year
2026: 3 · 2025: 10 · 2024: 4 · 2023: 9 · 2022: 14 · 2021: 9 · 2020: 10 · 2019: 16 · 2018: 4
FWCI
7.75
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Leona M. and Harry B. Helmsley Charitable Trust
  • U.S. Public Health Service (UL1-TR-001878, P30-DK-19525)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 1 diabetes, exercise-induced hypoglycemia, glucagon, insulin pump therapy, hyperglycemia
MeSH terms
Adult, Blood Glucose, Diabetes Mellitus, Type 1, Dose-Response Relationship, Drug, Fasting, Female, Glucagon, Glucose, Humans, Hypoglycemia, Insulin, Insulin Infusion Systems, Male, Exercise, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.